Sign in

CIK 0001595097

  • Non-accelerated filer
  • Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464348039
Phone
+1 617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
  1. 4 Open-market buy Chief Executive Officer bought 3,250 shares at $6.01 ($19,539)
  2. 4 Open-market buy Chief Medical Officer bought 4,233 shares at $9.49 ($40,171)
  3. 4 Exercise or conversion Chief Executive Officer acquired 20,000 shares (option exercise)
  4. 4 Open-market buy Chief Financial Officer bought 2,000 shares at $9.60 ($19,200)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4/A Open-market buy Chief Executive Officer bought 1,340 shares at $7.64 ($10,238)
  10. 4 Open-market buy Chief Financial Officer bought 1,500 shares at $7.20 ($10,800)
  11. 4 Open-market buy Chief Medical Officer bought 1,000 shares at $7.75 ($7,750)
  12. 4 Open-market buy Chief Executive Officer bought 1,340 shares at $7.64 ($10,238)
  13. 4 Open-market buy Director bought 1,000 shares at $7.49 ($7,490)
  14. 4 Open-market buy Director bought 2,000 shares at $7.55 ($15,100)
  15. 4 Open-market buy Director bought 10,000 shares at $7.00 ($69,960)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 17 · 340 filings